English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduA longer duration of treatment with puberty-delaying medications among transgender youth is associated with lower bone mineral density, according to a new study that will be presented Sunday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Tag: Endocrine Society
COVID-19 pandemic stress impacts ovulation
Life disruptions and the stresses of the COVID-19 pandemic led to disturbed ovulation with decreased progesterone durations or levels, according to research being presented Sunday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Adult growth hormone deficiency increases medical costs, risk of additional health conditions
Growth hormone deficiency (GHD) among adults is associated with greater medical costs and an increased rate of other health conditions compared with those without GHD, according to industry-sponsored research being presented Monday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Testosterone improves quality of life, sexual function, and delayed verbal recall in men with uncontrolled type 2 diabetes
Testosterone replacement therapy improved sexual symptoms, libido, symptom severity, delayed verbal recall and overall quality of life among people with poorly controlled type 2 diabetes and hypogonadism, according to research being presented Monday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Male contraceptive pills show promise in new study
Two experimental male contraceptive pills appear to effectively lower testosterone without causing unacceptable side effects, according to a new study that will be presented Monday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Chemicals in personal care products cause harmful effects in breast cancer cells from Black women
Chemicals called parabens, which are found in widely used hair and personal care products, cause harmful effects in breast cancer cells from Black women, according to a new study being presented Sunday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Endocrine-disrupting chemical exposure in womb impact fear, anxiety behavior in rats
Prenatal exposure to endocrine-disrupting chemicals found in everyday products may interfere with the developing offspring’s brain, according to a rat study being presented Monday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
AI can be used to identify benign thyroid nodules and reduce unnecessary biopsies
Artificial intelligence (AI) can be used to identify thyroid nodules seen on thyroid ultrasound that are very unlikely to be cancerous, reducing a large number of unnecessary biopsies, according to a new study being presented Saturday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Drinking coffee does not hinder the absorption of liquid thyroid medication
A new study conducted by Vertice Pharma confirms the absorption of an oral levothyroxine sodium solution (Thyquidity® 100g/ 5mL) was not affected by consuming coffee 5 minutes after the dose, according to research being presented Saturday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Probiotic bacteria may enhance tamoxifen effectiveness in treatment of ER+ breast cancer
Probiotic bacteria may enhance anti-cancer activities of the breast cancer drug tamoxifen and other endocrine-targeted therapies, which could help reduce the risk of estrogen receptive positive (ER+) breast cancer, suggests a new study presented Monday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Teens ate less ultra-processed food consumption during pandemic, reversing trend of three decades
For the first time in the last 30 years, the consumption of ultra-processed foods among teenagers in the United States declined during the COVID-19 pandemic, according to a new study presented at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
COVID-19 vaccination appears to be safe for patients treated for hypothyroidism
Inactivated and mRNA COVID-19 vaccines appear to be safe for patients treated for hypothyroidism,
according to a new study being presented at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga. The study found these vaccines do not cause significant fluctuations in thyroid function and are not associated with increased risks of emergency department visits or unscheduled hospitalizations.
Unhealthy diet helps explain association between food insecurity and obesity
There is a greater prevalence of obesity and higher body fat among people who face food insecurity, according to research being presented Sunday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Phase 3 study finds fezolinetant reduces the frequency and severity of menopausal hot flashes
Fezolinetant significantly reduced the frequency and severity of moderate-to-severe vasomotor symptoms (VMS), or hot flashes, associated with menopause, according to a Phase 3 industry-sponsored study being presented Saturday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Suppressed ovarian follicle development in women with obesity may explain reduced fertility
Women with obesity, even those with regular menstrual cycles, have suppressed ovarian follicle development and reduced production of reproductive hormones, which may underlie reduced fertility, according to a new study being presented Saturday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Analysis finds little evidence of heart problems in men undergoing testosterone treatment
Previous clinical trials have provided insufficient evidence to decide whether testosterone causes heart problems in men during the first year of treatment, according to research being presented Monday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga., and published in The Lancet Healthy Longevity.
Cedars-Sinai’s Dean, Shlomo Melmed, MB, ChB, Honored for Contributions to Endocrine Research
Shlomo Melmed, MB, ChB, a world-renowned leader in pituitary medicine, was named the inaugural recipient of the Transatlantic Alliance Award by the European Society of Endocrinology (ESE) and the Endocrine Society for his pioneering research in pituitary medicine and endocrine tumors.
Endocrine Society opposes Florida Department of Health policy on gender dysphoria treatment for children and adolescents
The Endocrine Society objects to the Florida Department of Health’s bulletin on gender-affirming care for transgender and gender-diverse youth. The bulletin contradicts the U.S. Department of Health & Human Services’ resources and the Society’s own evidence-based Clinical Practice Guideline regarding gender-affirming care.
Endocrine Society celebrates House passage of Build Back Better Act
The Endocrine Society hailed the House of Representatives for including provisions to improve insulin affordability in its version of the Build Back Better Act.
Endocrine Society honors endocrinology field’s leaders with 2022 Laureate Awards
The Endocrine Society today announced it has chosen 13 leading endocrinologists as winners of its prestigious 2022 Laureate Awards, the top honors in the field.
Endocrine Society celebrates Supreme Court decision to uphold the Affordable Care Act
The Endocrine Society today praised the U.S. Supreme Court’s decision to uphold the Affordable Care Act, which makes health care accessible to millions of individuals nationwide, including those with hormone health conditions such as diabetes, osteoporosis, thyroid conditions, and breast and prostate cancer.
Endocrine Society names new Editors-in-Chief of Endocrine Reviews, Journal of the Endocrine Society
The Endocrine Society appointed two new Editors-in-Chief of its prestigious journals. Ashley Grossman M.D., F.R.C.P., of Barts and the London School of Medicine in London, U.K., has been named the next Editor-in-Chief of Endocrine Reviews, and Zeynep Madak-Erdogan, Ph.D., of the University of Illinois at Urbana-Champaign in Urbana, Ill., has been named as Editor-in-Chief of the Journal of the Endocrine Society (JES).
Drug used during pregnancy may increase cancer risk in mother’s adult children
Exposure in the womb to a drug used to prevent miscarriage appears to raise the offspring’s cancer risk decades later, especially for colorectal and prostate cancers, researchers have found. They will present the results of their new study Tuesday at ENDO 2021, the Endocrine Society’s annual meeting.
High readmission rate found for adults with type 1 diabetes hospitalized for diabetic ketoacidosis
One in five adults with type 1 diabetes who require in-hospital treatment of the life-threatening condition diabetic ketoacidosis has an unplanned repeat hospital visit within a month and is twice as likely to die during the second hospitalization, a new study finds. The results, which will be presented at ENDO 2021, the Endocrine Society’s annual meeting, also identified several factors that increased the readmission risk for these patients.
COVID-19 can cause atypical thyroid inflammation
Some patients with moderate to severe COVID-19 disease seem to experience inflammation of the thyroid gland that is different from thyroid inflammation caused by other viruses, according to a study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
Genetic evidence suggests men can develop PCOS-like condition
New genetic research suggests men can develop characteristics of polycystic ovary syndrome (PCOS)—a common metabolic and reproductive disorder that affects women. The study was presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
Tubeless automated insulin delivery system improves blood glucose outcomes
People with type 1 diabetes can improve their blood sugar control while reducing time with low blood sugar, or hypoglycemia, using Insulet Corporation’s Omnipod 5 Automated Insulin Delivery System compared to their standard insulin therapy. Results from an industry-sponsored study of the latest Omnipod, the first tubeless, wearable insulin pump, will be presented at ENDO 2021, the Endocrine Society’s annual meeting.
First targeted therapy for children with achondroplasia shows persistent height gain for up to two years
Children with achondroplasia, the most common form of disproportionate short stature, grow taller with trends in improved body proportions after two years of daily vosoritide treatment, a new study analysis finds. Results of the industry-sponsored study will be presented at ENDO 2021, the Endocrine Society’s annual meeting.
“Hunger hormone” ghrelin affects monetary decision making
Higher levels of the stomach-derived hormone ghrelin, which stimulates appetite, predict a greater preference for smaller immediate monetary rewards over larger delayed financial rewards, a new study finds. The study results will be presented at ENDO 2021, the Endocrine Society’s annual meeting.
Semaglutide reduces excess body fat in people with obesity
In adults with obesity or overweight, weekly treatment with the glucagon-like peptide 1 (GLP1) receptor agonist semaglutide leads to reduced excess body fat and increased lean body mass, according to an industry-sponsored study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
Supplements may protect those with low vitamin D levels from severe COVID-19
Patients with low vitamin D levels who are hospitalized for COVID-19 may have a lower risk of dying or requiring mechanical ventilation if they receive vitamin D supplementation of at least 1,000 units weekly, according to a study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
Children, teens with type 1 diabetes had better glucose control during COVID-19 lockdown
Blood glucose levels improved among children and teens with type 1 diabetes during the first 12 weeks of COVID-19 lockdown in the United Kingdom, according to a study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
New treatment shows promise in preventing heart failure after heart attack
A study in mice finds treatment with a molecule called MCB-613 repairs heart tissue after a severe heart attack, preventing damage that can lead to heart failure. The findings are being presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
Night owls with gestational diabetes may face higher risk of pregnancy complications
Among women who develop diabetes during pregnancy, night owls have a higher risk of complications for mother and baby than early birds do, according to a study whose results will be presented at ENDO 2021, the Endocrine Society’s annual meeting.
Many endocrine patients, providers want to continue telehealth after pandemic
Two-thirds of patients with chronic endocrine health problems who need close monitoring say they would like to continue with telemedicine follow-up visits after the COVID-19 pandemic ends, according to a survey that will be presented virtually at ENDO 2021, the Endocrine Society’s annual meeting. Three-quarters of providers also said they want to continue with telehealth after the pandemic.
Study finds oral testosterone therapy undecanoate is effective, with no liver toxicity
An industry-supported study of an oral testosterone replacement therapy (TRT), testosterone undecanoate (TU, brand name Jatenzo) finds it is an effective, long-term treatment for men with low testosterone levels, with no evidence of liver toxicity. The findings are being presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
Combination thyroid hormone therapies treat hypothyroidism as well as levothyroxine
Treatment of hypothyroidism, which results from an underactive thyroid gland, should be individualized and consideration should be given to alternatives to the first-line therapy, including desiccated thyroid extract and combination therapy to replace the body’s two main thyroid hormones, thyroxine (T4) and triiodothyronine (T3). Results of their new randomized clinical study are being presented at ENDO 2021, the Endocrine Society’s annual meeting.
U.S. children from Spanish-speaking households experience higher rate of obesity than those from English-speaking families
Nearly one in five U.S. children and teenagers has obesity, and statistics show a higher prevalence of obesity in certain ethnicities, such as Hispanics and Blacks. Now results of a study being presented at ENDO 2021, the Endocrine Society’s annual meeting, suggest that Spanish as a family’s primary language is a predictor of childhood obesity, regardless of ethnicity.
Osteoporosis drug prescribing often does not follow guidelines
Less than one in 10 commercially insured patients in the United States who broke a hip, a major complication of osteoporosis, receive any osteoporosis medical treatment within two calendar quarters of their fracture, according to a study whose results will be presented at ENDO 2021, the Endocrine Society’s annual meeting.
Nearly one-third of older thyroid patients take medications that interfere with thyroid function tests
Nearly one-third of adults age 65 and older who take thyroid hormone also take medications that are known to interfere with thyroid function tests, according to a study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
Propylparaben exposure during pregnancy, breastfeeding may reduce protection against breast cancer
Low doses of propylparaben—an estrogen-like chemical used as a preservative in personal care products and foods—can alter pregnancy-related changes in the breast in ways that may reduce the normal protection against breast cancer that pregnancy hormones convey, according to a new study being published in the Endocrine Society’s journal Endocrinology.
Endocrine Society and partners to intervene in U.K. transgender medicine court appeal
The United Kingdom’s High Court has granted permission for a coalition of LGBTQ+, youth, reproductive health and medical organizations, including the Endocrine Society, to intervene in an appeal of its decision that minors under age 16 likely could not give informed consent for pubertal suppression.
Plastics pose threat to human health
Plastics contain and leach hazardous chemicals, including endocrine-disrupting chemicals (EDCs) that threaten human health. An authoritative new report, Plastics, EDCs, & Health, from the Endocrine Society and the IPEN (International Pollutants Elimination Network), presents a summary of international research on the health impacts of EDCs and describes the alarming health effects of widespread contamination from EDCs in plastics.
Pervasive plastics increase exposure to harmful chemicals
The Endocrine Society and IPEN will release a comprehensive joint report Dec. 15 on endocrine-disrupting chemicals in plastics and the threat they pose to public health. Experts will share highlights from the report during a virtual news conference Dec. 15.
Endocrine Society welcomes European Commission’s chemical strategy
The Endocrine Society welcomed the European Commission’s new Chemical Strategy for Sustainability and its measures to protect the public from endocrine-disrupting chemicals. The communication was released Wednesday as part of the European Green Deal.
Global Clinical Practice Guideline program to improve patient care
The Endocrine Society and the European Society of Endocrinology (ESE) have reached an historic agreement to jointly develop Clinical Practice Guidelines providing evidence-based recommendations for clinical care and practice.
Endocrine Society urges Congress to increase funding for NIH
The Endocrine Society—the world’s largest professional organization for endocrine scientists and physicians—is calling on Congress to pass the House Labor-HHS spending bill to ensure health agencies are funded before the start of Fiscal Year 2021 and to avoid the tumult and disruption of a continuing resolution and potential government shutdowns.
Endocrine Society names experienced endocrinologist interim CEO
The Endocrine Society has named Robert W. Lash, M.D.—an endocrinologist with more than 25 years of experience in the field—as its interim CEO.
Endocrine Society opposes Administration’s effort to roll back protections for transgender health
The Endocrine Society is alarmed by the Administration’s proposed rule to roll back protections for transgender individuals and narrow the scope of the Affordable Care Act (ACA), especially during the COVID-19 pandemic, when everyone needs access to health care. The Society calls on the Administration to maintain access to care protections for all, particularly vulnerable populations.
Heart attack, stroke risk declines among people with diabetes
The rate of heart attacks, strokes and other cardiovascular complications has improved among people with diabetes over the past 20 years, narrowing the gap in cardiovascular mortality rates between individuals with and without diabetes, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.